Thursday, November 29, 2012 8:18:02 AM
TEVA knew this was going to happen, and the BEST possible strategy to acquire the new shares they just announced would be right after a dilution. Bingo! Cheaper shares.
I had the initial reaction about a dilution, but this is positive. TEVA may also buy some of this offering, and I hope we find out soon. I think Rexahn has gotten a lot smarter about how they are spending their money, focusing on higher percentage chance of being successful: drugs on their oncology side.
Teva buying shares I believe is a setup for them to purchase Rexahn. They didn't have to do that, as they could have just contributed to RX-3117. The stock was optional. The only thing I am surprised about is Rexahn attempting this at this low a price. I didn't think they would be able to do it (wait and see on that one) but we don't know if they already had interested parties that want in cheap. This is better than buying on the open market.
So if Rexahn pulls this off, I wonder where they will spend their money first. They have a few options besides 3117.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM